Human aortic valve calcification is associated with an osteoblast phenotype

Circulation

Volumn 107, Issue 17, 2003, Pages 2181-2184

  Rajamannan, Nalini M ^a,b   Subramaniam, Malayannan ^c   Rickard, David ^c   Stock, Stuart R ^b   Donovan, Janis ^c   Springett, Margaret ^c   Orszulak, Thomas ^c   Fullerton, David A ^a   Tajik, A J ^c   Bonow, Robert O ^a   Spelsberg, Thomas ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Calcium; Stenosis; Valves

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; HYDROXYAPATITE; OSTEOCALCIN; OSTEOPONTIN; PLEIOTROPHIN; SIALOPROTEIN;

AORTA VALVE; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; ELECTRON MICROSCOPY; ENERGY DISPERSIVE SPECTROSCOPY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MICRORADIOGRAPHY; MINERALIZATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROSCOPY; THREE DIMENSIONAL IMAGING; UNITED STATES;

AORTIC VALVE; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BONE AND BONES; CALCINOSIS; HUMANS; MICRORADIOGRAPHY; OSTEOBLASTS; OSTEOGENESIS; PHENOTYPE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTRUM ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038711036     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000070591.21548.69     Document Type: Article

References (15)

1. Lindroos M, Kupari M, Heikkila J. et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. 1993;21:1220-1225.
2. Ross J, Braunwald E. Aortic stenosis, Circulation. 1968; 381(suppl):61-67.
3. Mohler ER, Gannon F, Reynolds C. et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522-1528.
4. O'Brien KD, Kuusisto J, Reichenbach DD, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation. 1995:92:2163-2168.
5. Mohler ER, Chawla MK, Chang AW, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis. 1999;8:254-260.
6. Rajamannan NM, Subramaniam M, Springett M, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation. 2002;105:2660-2665.
7. Jowsey J. Age changes in human bone. Clin Orthop. 1960:17:210-218.
8. Tissue and Special Stains Catalog. Rochester. Minn: Mayo Medical Laboratories, Mayo Clinic and Mayo Foundation; 1993.
9. Rickard DJ, Kassem M, Hefferan T, et al. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res. 1996;11:312-324.
10. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997;89:755-784.
11. Shavelle DM, Takasu J, Budoff MJ, et al. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 2002;359:1125-1126.
12. Gehron Robey P, Boskey AL. The biochemistry of bone. In: Marcus R. Feldman D. eds. Osteoporosis. New York: Raven Press; 1996:95-184.
13. Aubin JE, Liu F, Malaval L, et al. Osteoblast and chondroblast differentiation. Bone. 1995:17:77S-83S.
14. Karsenty G, Ducy P, Starbuck M, et al. Cbfa1 as a regulator of osteoblast differentiation and function. Bone. 1999;25:107-108.
15. Watson KE, Bostrom K, Ravindranath R, et al. TGF-beta I and 25-hydroxycholesterol stimulate osteoblast-like vascular cell to calcify. J Clinic Invest. 1994;93:2106-2013.